← Open Payments lookup

REBECCA DALTON: Open Payments

NPI 1619675766 · FESTUS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$639 in 37 payments from 12 companies in 2025. Trend: 2023 $320 · 2024 $559 · 2025 $639

Food & beverage: $639
CompanyPaymentsAmount
ABBVIE INC.15$152
Janssen Pharmaceuticals, Inc5$94
Neurocrine BioSciences, Inc.2$68
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$63
E.R. Squibb & Sons, L.L.C.3$61
Otsuka America Pharmaceutical, Inc.2$55
Vanda Pharmaceuticals Inc.2$54
AstraZeneca Pharmaceuticals LP1$23
Grifols USA, LLC1$20
Takeda Pharmaceuticals U.S.A., Inc.1$19

Products named: VRAYLAR, REXULTI, INGREZZA, CAPLYTA, COBENFY, INVEGA SUSTENNA, FANAPT, SPRAVATO.

Industry payments across MO — which companies pay providers there.